Avanti Polar Lipids

Form 483FOIA Uncovered

Alabaster, Alabama, United StatesFEI 1036868Issued July 07, 2023

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 1036868.

Observations1

Issue DateJuly 07, 2023

StatusNo Warning Letter

Related Inspections7

Establishment Details

Firm: Avanti Polar Lipids
Location: Alabaster, Alabama, United States
FEI Number: 1036868
Product Type: Drugs
Issue Date: July 07, 2023
Country: United States

Inspection History, 2010 to 2023

NAI4

VAI3

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Avanti Polar Lipids FDA Form 483, Alabaster, Alabama, July 7, 2023